Urology Doctors in Deland, FL Accepting Medicare

4 Urology doctors found. Showing 1 - 4

Stephen G Weiss Ii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 685 Peachwood Dr, Deland, FL 32720 Phone: 386-736-3463

Arash Rafiei, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 685 Peachwood Dr, Deland, FL 32720 Phone: 386-736-3463

Michael S Grable, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 685 Peachwood Dr, Deland, FL 32720 Phone: 386-736-3463

Robert W Lankford, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 685 Peachwood Dr, Deland, FL 32720 Phone: 386-736-3463

News Archive

Lancet World Report examines health risks associated with inaccurate TB tests, WHO's upcoming recommendations

With "scores of commercial serology tests for tuberculosis ... being sold in high-burden countries," the "WHO is due to release a negative policy recommendation - the first of its kind for the organisation" - after several reviews have "indicated poor performance of these tests," Lancet World Report writes in a piece that documents the health risks associated with a growing number of inaccurate TB tests.

Exact magnitude of stillbirths, maternal and neonatal mortality underreported, WHO reveals

The day of birth is potentially the most dangerous time for mothers and babies. Every year, worldwide, 303 000 women die during pregnancy and childbirth, 2.7 million babies die during the first 28 days of life and 2.6 million babies are stillborn.

Researchers identify control of a mitochondrial protective mechanism

Mitochondria are known as the "powerhouses" of cells. However, under critical pathophysiological conditions, they can use cellular energy for self-preservation.

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.

Read more Medical News

› Verified 2 days ago